Lv2
138 积分 2023-09-07 加入
Covariate adjustment in randomized controlled trials: General concepts and practical considerations
1个月前
已完结
Association Between 24-Hour Systolic Blood Pressure Time in Target Range and Mortality
2个月前
已完结
Association Between 24-Hour Systolic Blood Pressure Time in Target Range and Mortality
2个月前
已完结
Considerations on Interim Evaluation of OS in Pivotal Oncology Trials
7个月前
已完结
Robust Design and Analysis of Clinical Trials With Nonproportional Hazards: A Straw Man Guidance From a Cross-Pharma Working Group
7个月前
已完结
Robust Design and Analysis of Clinical Trials With Non-proportional Hazards: A Straw Man Guidance from a Cross-pharma Working Group
7个月前
已关闭
Critical review of oncology clinical trial design under non-proportional hazards
7个月前
已完结
Statistical considerations for evaluating treatment effect under various non-proportional hazard scenarios
8个月前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
8个月前
已完结
Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study
10个月前
已完结